AlloVir Inc’s net profit fell -18.76% since last year same period to $-44.64Mn in the Q2 2022. On a quarterly growth basis, AlloVir Inc has generated -1.77% fall in its net profits since last 3-months.
EPS Estimate Current Quarter
EPS Estimate Current Year
AlloVir Inc’s earning per share (EPS) estimates for the current quarter stand at -0.73 - a 8.75% jump from last quarter’s estimates.
AlloVir Inc’s earning per share (EPS) estimates for the current year stand at -0.73.
Return on Assets (ROA)
Return on Equity (ROE)
Dividend Per Share (DPS)
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. AlloVir Inc’s return on assets (ROA) stands at -0.45.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. AlloVir Inc’s return on equity (ROE) stands at -0.83.
AlloVir Inc declared 0 dividend per share during the earnings announcement for Q2 2022.
|Earnings Date||Estimated EPS||Reported EPS||Surprise %|